A bone marrow transplant is often the only therapy available to save leukaemia patients, but the risk of complications is high. Nearly half of all patients experience an unwanted reaction of their immune system, which often attacks their skin and liver and in up to 50 percent of cases the intestines. Researchers have succeeded in deciphering what causes this in some instances life-threatening inflammation of the intestines.